Zoledronic acid

Zoledronic acid is the generic name for an osteoporosis medicine with the brand name Reclast®, a product of Novartis. No generic version of Reclast is available since the patent for Reclast is still in effect until 2013; however, other circumstances, such as lawsuits, could delay this.  Refer to Reclast entry for information about this medicine.

Other Resources:

Reclast Product Website